Aktuellt
SENASTE
Biovica’s clinical support continues to expand substantially, and this adds to the launch support during 2022. Biovica also points to external interest and opportunities to add companion diagnostic collaboration with pharma companies. FDA is still not ready to get a green light to submit the updated FDA application, and Biovica does not expect to get approval before the end of the year.
LÄS MER
